P. Strauss

Mechanistic Evidence in Support of Alpha1-Antitrypsin as a Therapeutic Approach for Type 1 Diabetes

E. Lewis, Gabriella Fleixo-Lima, Hilla Ventura, 2014, Journal of diabetes science and technology.

Alpha‐1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitus

M. Phillip, M. Rachmiel, Z. Landau, 2016, Pediatric diabetes.

Biochemical Efficacy and Safety of a New, Ready-to-Use, Liquid Alpha-1-Proteinase Inhibitor, GLASSIA (Alpha1-Proteinase Inhibitor (Human), Intravenous)

R. Sandhaus, Farshid N. Rouhani, M. Brantly, 2014, COPD.

Exploration of α1-Antitrypsin Treatment Protocol for Islet Transplantation: Dosing Plan and Route of Administration

Eran B. Schenker, D. Ochayon, E. Lewis, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Mechanistic Evidence in Support of Alpha1-Antitrypsin as a Therapeutic Approach for Type 1 Diabetes

E. Lewis, Gabriella Fleixo-Lima, Hilla Ventura, 2014, Journal of diabetes science and technology.